Open AccessSirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria
Author(s) -
Sunbin Ling,
Tingting Feng,
Qifan Zhan,
Xin Duan,
Guangjiang Jiang,
Shen Tian,
Qiaonan Shan,
Shengjun Xu,
Qianwei Ye,
Peng Liu,
Beini Cen,
Shusen Zheng,
Xiao Xu
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.01.10
Subject(s) - sirolimus , hepatocellular carcinoma , medicine , immunosuppression , milan criteria , calcineurin , liver transplantation , transplantation , gastroenterology , oncology , proportional hazards model , overall survival , surgery
SRL can improve survival outcomes in LT patients with HCC exceeding the Hangzhou criteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom